Amit EtkinFounder

United States - Stanford, California

Amit is the founder and CEO of Alto Neuroscience, a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions. Amit is trained as a psychiatrist and neuroscientist, and has been on the Stanford faculty since 2010. As a tenured Professor, he became an international leader in the neuroscience of psychiatric disorders and their treatments. In recognition of the influence of his ideas and work, Amit received the most competitive and prestigious NIH grant – the Director’s Pioneer Award – the first one given in clinical psychiatry. He has also consistently ranked in the top 0.1% of researchers by citations.

Amit brings broad-based scientific and programmatic leadership and a compelling vision for connecting scientific discovery to pragmatic clinical and business goals. He has a proven track record of success in publication in the highest-impact journals, raising extensive public and private funding, and managing a large and diverse team of scientists, clinicians and engineers towards a shared scientific vision. His training and experience span from molecular biology, having done his PhD with Nobel Laureate Eric Kandel, through to human clinical and neuroscience studies, machine learning, and clinical trials – a breadth and perspective critical to the innovation Alto is bringing to precision psychiatry.